Dr Holger Becker, Chief Scientific Officer of microfluidic ChipShop GmbH, discusses the great potential of microfluidics in our latest blog entry – http://bit.ly/15HpwvN.
Dr Becker will also be running a training course on ‘Microfluidics from the Concept to a Product: Technologies, Applications and Commercialisation Strategies’ at ELA on June 5th http://bit.ly/13ovJPE
Keynote talk to be delivered by Dr Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Center 'Illuminating Cellular Pathways through Combining High Content Assays with the BDA Method: Too Much Hay and Very Few Needles in Random RNAi Screening Stacks' at the DDA: High-content Screening & Cell Based Assays conference track at ELA. For the full agenda, please view: http://bit.ly/YSUu0P
In the run up to European Lab Automation 2013, we’ll be sharing some interesting news and insights around the event on our new blog - http://tinyurl.com/aafeu9f .
We’d be delighted if you’d like to comment on some of our blog posts, adding your own thoughts and generally become a valued part of the conversation!
We understand that staying up-to-date on the latest technologies boosting efficiency and effectiveness in the lab can be challenging. That’s exactly why we created ELA.
Our latest blog entry - http://bit.ly/15HpwvN - highlights five key reasons not to miss this year’s event, all based on feedback we’ve received from past attendees.
This week’s blog focusses on the ethical issues surrounding biobanking, based on a recent interview we conducted with Zubin Master. Dr Master, Assistant Professor at the Alden March Bioethics Institute of Albany Medical College, will be discussing this topic in detail at ELA 2013 as part of his presentation, “Biobanks: Consent, Consensus & Public Trust.”
Dr Stephan Schürer from the University of Miami speaks about the goals of the BioAssay Ontology Project to enable standardized description, integration and meta-analysis of assay and screening results - http://bit.ly/15HpwvN
Dr Schürer will be discussing this topic in more detail at ELA 2013 as part of the Drug Discovery Automation track - http://bit.ly/16jbuPq